Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Opioid Use Disorder (OUD) Market, by Drug Class
1.4.2 North America Opioid Use Disorder (OUD) Market, by Route of Administration
1.4.3 North America Opioid Use Disorder (OUD) Market, by Distribution Channel
1.4.4 North America Opioid Use Disorder (OUD) Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Opioid Use Disorder (OUD) Market
Chapter 4. North America Opioid Use Disorder (OUD) Market by Drug Class
4.1 North America Buprenorphine Market by Country
4.2 North America Methadone Market by Country
4.3 North America Naltrexone Market by Country
Chapter 5. North America Opioid Use Disorder (OUD) Market by Route of Administration
5.1 North America Parenteral Market by Country
5.2 North America Oral Market by Country
Chapter 6. North America Opioid Use Disorder (OUD) Market by Distribution Channel
6.1 North America Hospital Pharmacies Market by Country
6.2 North America Retail Pharmacies & Stores Market by Country
6.3 North America Online Pharmacies Market by Country
Chapter 7. North America Opioid Use Disorder (OUD) Market by Country
7.1 US Opioid Use Disorder (OUD) Market
7.1.1 US Opioid Use Disorder (OUD) Market by Drug Class
7.1.2 US Opioid Use Disorder (OUD) Market by Route of Administration
7.1.3 US Opioid Use Disorder (OUD) Market by Distribution Channel
7.2 Canada Opioid Use Disorder (OUD) Market
7.2.1 Canada Opioid Use Disorder (OUD) Market by Drug Class
7.2.2 Canada Opioid Use Disorder (OUD) Market by Route of Administration
7.2.3 Canada Opioid Use Disorder (OUD) Market by Distribution Channel
7.3 Mexico Opioid Use Disorder (OUD) Market
7.3.1 Mexico Opioid Use Disorder (OUD) Market by Drug Class
7.3.2 Mexico Opioid Use Disorder (OUD) Market by Route of Administration
7.3.3 Mexico Opioid Use Disorder (OUD) Market by Distribution Channel
7.4 Rest of North America Opioid Use Disorder (OUD) Market
7.4.1 Rest of North America Opioid Use Disorder (OUD) Market by Drug Class
7.4.2 Rest of North America Opioid Use Disorder (OUD) Market by Route of Administration
7.4.3 Rest of North America Opioid Use Disorder (OUD) Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Indivior PLC (Reckitt Benckiser Group plc)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Product and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Collegium Pharmaceutical, Inc. (BioDelivery Sciences International, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.3 Orexo AB (Orexo US, Inc.)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Alkermes PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Trials and Approvals:
8.5 Titan Pharmaceuticals, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Trials and Approvals:
8.6 Camurus AB
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Trials and Approvals:
8.7 AstraZeneca PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Hikma Pharmaceuticals PLC
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Product Launches and Product Expansions:
8.9 Mallinckrodt PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Viatris, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental Analysis
8.10.4 Research & Development Expense



List of Figures

FIG 1 Methodology for the research
FIG 2 North America Opioid Use Disorder (OUD) Market share by Drug Class, 2022
FIG 3 North America Opioid Use Disorder (OUD) Market share by Drug Class, 2030
FIG 4 North America Opioid Use Disorder (OUD) Market by Drug Class, 2019 - 2030, USD Million
FIG 5 North America Opioid Use Disorder (OUD) Market share by Route of Administration, 2022
FIG 6 North America Opioid Use Disorder (OUD) Market share by Route of Administration, 2030
FIG 7 North America Opioid Use Disorder (OUD) Market by Route of Administration, 2019 - 2030, USD Million
FIG 8 North America Opioid Use Disorder (OUD) Market share by Distribution Channel, 2022
FIG 9 North America Opioid Use Disorder (OUD) Market share by Distribution Channel, 2030
FIG 10 North America Opioid Use Disorder (OUD) Market by Distribution Channel, 2019 - 2030, USD Million
FIG 11 North America Opioid Use Disorder (OUD) Market share by Country, 2022
FIG 12 North America Opioid Use Disorder (OUD) Market share by Country, 2030
FIG 13 North America Opioid Use Disorder (OUD) Market by Country, 2019 - 2030, USD Million

List of Tables

TABLE 1 North America Opioid Use Disorder (OUD) Market, 2019 - 2022, USD Million
TABLE 2 North America Opioid Use Disorder (OUD) Market, 2023 - 2030, USD Million
TABLE 3 North America Opioid Use Disorder (OUD) Market by Drug Class, 2019 - 2022, USD Million
TABLE 4 North America Opioid Use Disorder (OUD) Market by Drug Class, 2023 - 2030, USD Million
TABLE 5 North America Buprenorphine Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Buprenorphine Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Methadone Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Methadone Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Naltrexone Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Naltrexone Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Opioid Use Disorder (OUD) Market by Route of Administration, 2019 - 2022, USD Million
TABLE 12 North America Opioid Use Disorder (OUD) Market by Route of Administration, 2023 - 2030, USD Million
TABLE 13 North America Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Parenteral Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Oral Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Oral Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Opioid Use Disorder (OUD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 North America Opioid Use Disorder (OUD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 19 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Retail Pharmacies & Stores Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Retail Pharmacies & Stores Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Online Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Opioid Use Disorder (OUD) Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Opioid Use Disorder (OUD) Market by Country, 2023 - 2030, USD Million
TABLE 27 US Opioid Use Disorder (OUD) Market, 2019 - 2022, USD Million
TABLE 28 US Opioid Use Disorder (OUD) Market, 2023 - 2030, USD Million
TABLE 29 US Opioid Use Disorder (OUD) Market by Drug Class, 2019 - 2022, USD Million
TABLE 30 US Opioid Use Disorder (OUD) Market by Drug Class, 2023 - 2030, USD Million
TABLE 31 US Opioid Use Disorder (OUD) Market by Route of Administration, 2019 - 2022, USD Million
TABLE 32 US Opioid Use Disorder (OUD) Market by Route of Administration, 2023 - 2030, USD Million
TABLE 33 US Opioid Use Disorder (OUD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 US Opioid Use Disorder (OUD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 35 Canada Opioid Use Disorder (OUD) Market, 2019 - 2022, USD Million
TABLE 36 Canada Opioid Use Disorder (OUD) Market, 2023 - 2030, USD Million
TABLE 37 Canada Opioid Use Disorder (OUD) Market by Drug Class, 2019 - 2022, USD Million
TABLE 38 Canada Opioid Use Disorder (OUD) Market by Drug Class, 2023 - 2030, USD Million
TABLE 39 Canada Opioid Use Disorder (OUD) Market by Route of Administration, 2019 - 2022, USD Million
TABLE 40 Canada Opioid Use Disorder (OUD) Market by Route of Administration, 2023 - 2030, USD Million
TABLE 41 Canada Opioid Use Disorder (OUD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Canada Opioid Use Disorder (OUD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 43 Mexico Opioid Use Disorder (OUD) Market, 2019 - 2022, USD Million
TABLE 44 Mexico Opioid Use Disorder (OUD) Market, 2023 - 2030, USD Million
TABLE 45 Mexico Opioid Use Disorder (OUD) Market by Drug Class, 2019 - 2022, USD Million
TABLE 46 Mexico Opioid Use Disorder (OUD) Market by Drug Class, 2023 - 2030, USD Million
TABLE 47 Mexico Opioid Use Disorder (OUD) Market by Route of Administration, 2019 - 2022, USD Million
TABLE 48 Mexico Opioid Use Disorder (OUD) Market by Route of Administration, 2023 - 2030, USD Million
TABLE 49 Mexico Opioid Use Disorder (OUD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 Mexico Opioid Use Disorder (OUD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 51 Rest of North America Opioid Use Disorder (OUD) Market, 2019 - 2022, USD Million
TABLE 52 Rest of North America Opioid Use Disorder (OUD) Market, 2023 - 2030, USD Million
TABLE 53 Rest of North America Opioid Use Disorder (OUD) Market by Drug Class, 2019 - 2022, USD Million
TABLE 54 Rest of North America Opioid Use Disorder (OUD) Market by Drug Class, 2023 - 2030, USD Million
TABLE 55 Rest of North America Opioid Use Disorder (OUD) Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 Rest of North America Opioid Use Disorder (OUD) Market by Route of Administration, 2023 - 2030, USD Million
TABLE 57 Rest of North America Opioid Use Disorder (OUD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Rest of North America Opioid Use Disorder (OUD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 Key Information – Indivior PLC (Reckitt Benckiser Group plc)
TABLE 60 Key Information – collegium pharmaceutical
TABLE 61 Key Information – Orexo AB
TABLE 62 Key Information – Alkermes PLC
TABLE 63 Key Information –?Titan Pharmaceuticals, Inc.
TABLE 64 Key Information – Camurus AB
TABLE 65 KEY INFORMATION – AstraZeneca PLC
TABLE 66 Key Information – Hikma Pharmaceuticals PLC
TABLE 67 Key information – Mallinckrodt PLC
TABLE 68 key information – Viatris, Inc.